NEW YORK (GenomeWeb) – BGI today said that it anticipates hiring 100 people for its Hong Kong office this year in order to meet growing business demand.

Established in 2010, BGI-Hong Kong currently employs about 140 people, and is applying for various international quality certifications with plans to conduct personalized genome sequencing for preventing and curing illnesses, BGI said.

"We expect to enter 10 to 20 new overseas markets next year via our Hong Kong research center," Sunny Cheung, laboratory manager of BGI Tech Solutions in Hong Kong, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.